Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human GRB2 (SH2 Domain) Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications
Supplier: R&D Systems MAB38461
This item is not returnable.
View return policy
Description
GRB2 Monoclonal specifically detects GRB2 in Human samples. It is validated for Western Blot, Immunohistochemistry.Specifications
GRB2 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL | |
P62993 | |
GRB2 | |
E. coli-derived recombinant human GRB2 (SH2 Domain) Trp60-Glu152 Accession # P62993 | |
100 μg | |
Primary | |
Detects human GRB2 (SH2 Domain) in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) GRAP2 (SH2 domain; aa 58-149), rhGRB7 (aa 130-274), or rhGRB14 (SH2 domain; aa 439-535) is observed. | |
Human | |
Purified |
Western Blot, Immunohistochemistry | |
669604 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
abundant SRC homology, Adapter protein GRB2, ASH, EGFRBP-GRB2, epidermal growth factor receptor-binding protein GRB2, Grb3-3, growth factor receptor-bound protein 2, growth factor receptor-bound protein 3, HT027, MST084, MSTP084, NCKAP2, Protein Ash, SH2/SH3 adapter GRB2 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
2885 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction